Home > Products > CD2 & EGFR
> Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (Miniantibody)
Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (Miniantibody) (CAT#: MNAB-046)
Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (Miniantibody) is a fusion protein of two scFv fragments combined with distinct specificity. One scFv of an anti-CD2 antibody variable domain is linked to another scFv of an anti-EGFR antibody variable domain by a flexible hinge region. This BsAb format has the decreased size and better penetration than conventional IgGs in the clinical diagnostics and potentially therapy. This BsAb can retarget T cells to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy.
Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors
There are currently no customer reviews or questions for Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (Miniantibody) (MNAB-046). Click the button below to contact us or submit your feedback about this product.